checkAd

Ambu Names Britt Meelby Jensen New CEO Following Departure of Gonzalez; Guidance Unchanged

(PLX AI) –Ambu says Juan Jose Gonzalez will leave Ambu after three years with the company. One-off costs associated with the change of CEO of DKK 13m will be accounted for in the interim report for Q3 2021/22Says announcement does not change the …

  • (PLX AI) –Ambu says Juan Jose Gonzalez will leave Ambu after three years with the company.
  • One-off costs associated with the change of CEO of DKK 13m will be accounted for in the interim report for Q3 2021/22
  • Says announcement does not change the financial guidance for 2021/22 as provided in the interim report for Q2 2021/22 on 5 May 2022
  • From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until the sale of the company to Coloplast in early 2022
  • From 2015 to 2019, Britt Meelby Jensen served as CEO of Zealand Pharma


0 Kommentare
Autor: PLX AI
 |  208   |   |   

Schreibe Deinen Kommentar

Disclaimer

Ambu Names Britt Meelby Jensen New CEO Following Departure of Gonzalez; Guidance Unchanged (PLX AI) –Ambu says Juan Jose Gonzalez will leave Ambu after three years with the company. One-off costs associated with the change of CEO of DKK 13m will be accounted for in the interim report for Q3 2021/22Says announcement does not change the …

Nachrichten des Autors

Titel
Titel
Titel
Titel